Dr. Frederick Matthew Howard, MD

Dr. Howard practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.

Dr. Howard's NPI, 1326427923, was assigned on May 28, 2015. Dr. Howard graduated from University of Michigan Medical School in 2015. Dr. Howard holds Illinois license 036.148921.

Dr. Howard's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Dr. Howard's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Dr. Howard is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Dr. Howard to 1 more home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Howard practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Howard's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Howard's licenses on file in 2 states: Illinois and Connecticut.

CMS data shows 119 Medicare services from Dr. Howard across 3 procedure codes in 2024, for 48 Medicare patients. Medicare paid $10,604 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 48 Medicare patients who saw Dr. Howard in 2024. The largest group is 65 to 74, with 21 patients. 75% of them have high blood pressure, and 69% have cancer. 42% are also on Medicaid. Their average risk score is 2.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Howard's median patient age at 70, with 93% women.

In 2024, Dr. Howard wrote 246 Medicare Part D claims for 46 patients. 70% of them were for generic drugs. CMS names the drug for 128 of them, across 5 drugs with 11 or more claims each, at $713,756 in total drug cost. In 2023, CMS named 83 claims across 3 drugs.

Dr. Howard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Howard as offering telehealth.

Dmand AI links 48 papers to Dr. Howard, published from 2012 to 2025. 2024 was the busiest year, with 13. The most frequent topics are Breast Neoplasms, Neoadjuvant Therapy and Deep Learning. Dr. Howard has published most often in JAMA Netw Open. Dr. Howard's most frequent co-authors are Rita Nanda, Alexander T. Pearson and James Matthew Dolezal, MD.

CMS Open Payments shows 7 general payments to Dr. Howard from 4 drug and device companies from 2023 to 2025. Travel and lodging make up the largest share, 52% of the total. Novartis Pharma AG paid the most, $20,016. It also lists 2 research payments totaling $2,596 from 2024 to 2025.

Dr. Howard graduated from University of Michigan Medical School in 2015.